Clinical Trial Detail

NCT ID NCT01737502
Title Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Mayo Clinic
Indications

lung small cell carcinoma

lung adenocarcinoma

lung squamous cell carcinoma

Therapies

Auranofin + Sirolimus

Age Groups: adult senior

Additional content available in CKB BOOST